Bairam Kochiyev
Bairam Kochiyev has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Aslan Karimov
National Research Oncology Center
2 shared publications Zhandos Burkitbayev
National Research Oncology Center
2 shared publications- Aibar Aginbay
Department of Gastroenterology, National Research Oncology Center, Astana, Kazakhstan
1 shared publication Aigerim Tanyrbergenova
National Research Oncology Center, Astana, Kazakhstan
1 shared publicationAigerim Temirbayeva
National Research Oncology Center
1 shared publication- Ainur Bilmakhanbetova
Department of Public Health and Management, NJSC “Astana Medical University”, Astana 010000, Kazakhstan
1 shared publication
Latest Publications
- 17 June 2026
- Published by SAGE Publications in Molecular Imaging
- Vol. 25
Radiomic Analysis of MRI for Assessing Response to Neoadjuvant Chemoradiotherapy in Rectal Adenocarcinoma: A Systematic Review and Metaanalysis
Background: This study aimed to evaluate the diagnostic performance of magnetic resonance imaging (MRI)-based radiomics for predicting pathological complete response (pCR) after neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma. Methods: Eligible studies developed MRI-based radiomics or deep learning models to predict pCR and reported sufficient data to reconstruct 2 × 2 contingency tables. Only validation cohorts were included in the quantitative synthesis. Study quality was assessed using Quality Assessment of Diagnostic Accuracy Studies-2 and the Radiomics Quality Score. Pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio were estimated using a bivariate random-effects model. Hierarchical summary receiver operating characteristic (HSROC) analysis was performed. Results: Thirty-eight studies were included. The pooled sensitivity and specificity were 0.82 (95% CI, 0.71-0.90) and 0.86 (95% CI, 0.80-0.91), respectively. The pooled PLR and NLR were 6.0 (95% CI, 4.0-8.9) and 0.21 (95% CI, 0.12-0.35), corresponding to a diagnostic odds ratio of 29 (95% CI, 14-61). HSROC analysis showed an area under the curve of 0.846. Subgroup analyses suggested improved performance for deep learning and combined clinical–radiomic models. Conclusion: MRI-based radiomics demonstrates good diagnostic accuracy for predicting pCR after neoadjuvant chemoradiotherapy in rectal cancer, although methodological heterogeneity and limited prospective validation remain challenges.
- 17 June 2026
- Published by SAGE Publications in Molecular Imaging
- Vol. 25
Radiomic Analysis of MRI for Assessing Response to Neoadjuvant Chemoradiotherapy in Rectal Adenocarcinoma: A Systematic Review and Metaanalysis
Background: This study aimed to evaluate the diagnostic performance of magnetic resonance imaging (MRI)-based radiomics for predicting pathological complete response (pCR) after neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma. Methods: Eligible studies developed MRI-based radiomics or deep learning models to predict pCR and reported sufficient data to reconstruct 2 × 2 contingency tables. Only validation cohorts were included in the quantitative synthesis. Study quality was assessed using Quality Assessment of Diagnostic Accuracy Studies-2 and the Radiomics Quality Score. Pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio were estimated using a bivariate random-effects model. Hierarchical summary receiver operating characteristic (HSROC) analysis was performed. Results: Thirty-eight studies were included. The pooled sensitivity and specificity were 0.82 (95% CI, 0.71-0.90) and 0.86 (95% CI, 0.80-0.91), respectively. The pooled PLR and NLR were 6.0 (95% CI, 4.0-8.9) and 0.21 (95% CI, 0.12-0.35), corresponding to a diagnostic odds ratio of 29 (95% CI, 14-61). HSROC analysis showed an area under the curve of 0.846. Subgroup analyses suggested improved performance for deep learning and combined clinical–radiomic models. Conclusion: MRI-based radiomics demonstrates good diagnostic accuracy for predicting pCR after neoadjuvant chemoradiotherapy in rectal cancer, although methodological heterogeneity and limited prospective validation remain challenges.
- Open Access
- 23 April 2026
- Published by Australasia Publishing Group in Oncology, Nuclear Medicine and Transplantology
- Vol. 2 (2) , onmt017
Malignant Transformation of Hepatocellular Adenoma: Case Report
Hepatocellular adenomas (HCA) are rare benign liver tumors associated with metabolic risk factors and carry a risk of malignant transformation. We present a case of a 50-year-old woman with a liver lesion initially diagnosed as a hepatocellular adenoma that showed progressive growth on follow-up imaging. Contrast-enhanced MRI (Magnetic Resonance Imaging) and CT (Computed Tomography) showed enlargement of the lesion in segments S6–S7. Initial biopsy findings were consistent with hepatocellular adenoma. Because of continued tumor growth, right liver resection was performed. Histopathological examination revealed foci of well-differentiated hepatocellular carcinoma arising within a dysplastic adenoma with areas of necrosis. This case highlights the diagnostic challenges in distinguishing hepatocellular adenoma from early hepatocellular carcinoma, particularly in patients with metabolic risk factors and progressive tumor enlargement. It emphasizes the importance of careful imaging surveillance and timely surgical management.
- 23 April 2026
- Published by Australasia Publishing Group in Oncology, Nuclear Medicine and Transplantology
- Vol. 2 (2) , onmt017
Open AccessMalignant Transformation of Hepatocellular Adenoma: Case Report
Hepatocellular adenomas (HCA) are rare benign liver tumors associated with metabolic risk factors and carry a risk of malignant transformation. We present a case of a 50-year-old woman with a liver lesion initially diagnosed as a hepatocellular adenoma that showed progressive growth on follow-up imaging. Contrast-enhanced MRI (Magnetic Resonance Imaging) and CT (Computed Tomography) showed enlargement of the lesion in segments S6–S7. Initial biopsy findings were consistent with hepatocellular adenoma. Because of continued tumor growth, right liver resection was performed. Histopathological examination revealed foci of well-differentiated hepatocellular carcinoma arising within a dysplastic adenoma with areas of necrosis. This case highlights the diagnostic challenges in distinguishing hepatocellular adenoma from early hepatocellular carcinoma, particularly in patients with metabolic risk factors and progressive tumor enlargement. It emphasizes the importance of careful imaging surveillance and timely surgical management.
- Open Access
- 7 January 2026
- Published by Australasia Publishing Group in Oncology, Nuclear Medicine and Transplantology
- Vol. 2 (1) , onmt013
A Rare Case of Cyclosporine-Induced Posterior Reversible Encephalopathy Syndrome in a Patient after Liver Transplantation
Posterior reversible encephalopathy syndrome (PRES) is a neurological condition characterized by seizures, encephalopathy, visual disturbances, and headache, often occurring in the context of hypertension and immunosuppressive therapy after solid organ transplantation. Although classically presenting with vasogenic edema in the parieto-occipital regions, atypical patterns may also occur. Here we report our experience with a case of cyclosporine-related PRES after liver transplant and summarize PRES clinical features through a literature review. The case was a 53-year-old man who received a deceased donor liver transplant. His initial immunosuppressive therapy comprised cyclosporine/mycophenolate mofetil/prednisolone. Five months after transplantation, he was admitted to our center with altered mental status. The patient was diagnosed with PRES based on neurological symptoms and neuroimaging findings and recovered after switching from cyclosporine to everolimus. In addition, the lowering of blood pressure with drugs reported in the literature for use in PRES proved to be effective but challenging, requiring the use of multiple agents and only slowly leading to adequate control of hypertensive peaks. Nonetheless, hypertension management and supportive therapy allowed for a complete neurological recovery of the patient. In conclusion, cyclosporine-associated PRES has a generally favorable prognosis with early diagnosis and prompt treatment, including altering or discontinuing CNIs and controlling blood pressure. CNI-associated PRES should be considered in patients exhibiting acute neurological symptoms after transplantation. Early diagnosis and immediate treatment are critical for a favorable prognosis.
- 7 January 2026
- Published by Australasia Publishing Group in Oncology, Nuclear Medicine and Transplantology
- Vol. 2 (1) , onmt013
Open AccessA Rare Case of Cyclosporine-Induced Posterior Reversible Encephalopathy Syndrome in a Patient after Liver Transplantation
Posterior reversible encephalopathy syndrome (PRES) is a neurological condition characterized by seizures, encephalopathy, visual disturbances, and headache, often occurring in the context of hypertension and immunosuppressive therapy after solid organ transplantation. Although classically presenting with vasogenic edema in the parieto-occipital regions, atypical patterns may also occur. Here we report our experience with a case of cyclosporine-related PRES after liver transplant and summarize PRES clinical features through a literature review. The case was a 53-year-old man who received a deceased donor liver transplant. His initial immunosuppressive therapy comprised cyclosporine/mycophenolate mofetil/prednisolone. Five months after transplantation, he was admitted to our center with altered mental status. The patient was diagnosed with PRES based on neurological symptoms and neuroimaging findings and recovered after switching from cyclosporine to everolimus. In addition, the lowering of blood pressure with drugs reported in the literature for use in PRES proved to be effective but challenging, requiring the use of multiple agents and only slowly leading to adequate control of hypertensive peaks. Nonetheless, hypertension management and supportive therapy allowed for a complete neurological recovery of the patient. In conclusion, cyclosporine-associated PRES has a generally favorable prognosis with early diagnosis and prompt treatment, including altering or discontinuing CNIs and controlling blood pressure. CNI-associated PRES should be considered in patients exhibiting acute neurological symptoms after transplantation. Early diagnosis and immediate treatment are critical for a favorable prognosis.
- Open Access
- 1 January 2026
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 19 (1) , 758-766
Tumor-Related Pericardial and Myocardial Infiltration in Diffuse Large B-Cell Lymphoma Presenting as an ST-Elevation Myocardial Infarction Mimic: A Case Report
Background: Cardiac involvement in diffuse large B-cell lymphoma (DLBCL) is rare and often underrecognized. Concurrent pericardial and myocardial infiltration can mimic acute myocardial infarction on electrocardiography, posing diagnostic challenges. Case Presentation: We present a 64-year-old female with biopsy-confirmed DLBCL who developed acute respiratory symptoms and electrocardiographic changes mimicking ST-elevation myocardial infarction (STEMI). Multimodal imaging revealed a large pericardial effusion, myocardial infiltration, and no obstructive coronary disease. Despite chemotherapy and supportive care, the patient succumbed to cardiopulmonary failure. Conclusion: This case highlights a rare manifestation of lymphoma-associated cardio-infiltration presenting as STEMI mimic. Early multidisciplinary evaluation is essential to differentiate pseudo-infarction syndromes and prevent unnecessary invasive interventions.
- 1 January 2026
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 19 (1) , 758-766
Open AccessTumor-Related Pericardial and Myocardial Infiltration in Diffuse Large B-Cell Lymphoma Presenting as an ST-Elevation Myocardial Infarction Mimic: A Case Report
Background: Cardiac involvement in diffuse large B-cell lymphoma (DLBCL) is rare and often underrecognized. Concurrent pericardial and myocardial infiltration can mimic acute myocardial infarction on electrocardiography, posing diagnostic challenges. Case Presentation: We present a 64-year-old female with biopsy-confirmed DLBCL who developed acute respiratory symptoms and electrocardiographic changes mimicking ST-elevation myocardial infarction (STEMI). Multimodal imaging revealed a large pericardial effusion, myocardial infiltration, and no obstructive coronary disease. Despite chemotherapy and supportive care, the patient succumbed to cardiopulmonary failure. Conclusion: This case highlights a rare manifestation of lymphoma-associated cardio-infiltration presenting as STEMI mimic. Early multidisciplinary evaluation is essential to differentiate pseudo-infarction syndromes and prevent unnecessary invasive interventions.